Dr. Nitesh Rohatgi

Dr. Nitesh Rohatgi is the Principal Director of Medical Oncology at Fortis Memorial Research Institute in Gurgaon, India, bringing over 15 years of dedicated clinical expertise in cancer care. He holds prestigious international qualifications including Fellowship of the Royal College of Physicians (Edinburgh) and Fellowship of the Royal Society of Medicine (London), complemented by a postgraduate medical degree from Dundee, UK, and successful completion of oncology training in the UK (CCT, 2009). His clinical training spans medical oncology, palliative medicine, and teenage/young adult cancers in the United Kingdom, establishing a foundation of both Western and Indian oncological best practices.

Dr. Rohatgi specializes in the management of solid tumors through a comprehensive range of evidence-based approaches, including chemotherapy (adjuvant, neoadjuvant, and palliative), immunotherapy with immune checkpoint inhibitors, and molecular targeted therapies guided by biomarker analysis. He has served as a Principal Investigator on clinical trials and maintains an active publication record in peer-reviewed journals, positioning him as a key opinion leader in Indian oncology. His approach emphasizes personalized treatment planning, particularly in hormone therapies for breast and prostate cancers, and he routinely manages complex, multidisciplinary cases with clinical precision and scientific rigor.

Dr. Rohatgi is experienced in treating international patients from the Gulf region, Africa, and across South Asia, many of whom travel to Gurgaon for his specialized expertise. He brings a compassionate, patient-centered approach to cancer care, understanding the emotional and practical challenges faced by families navigating an oncology diagnosis. His fluency in English and Hindi ensures clear communication with diverse patient populations. Prior to his current role, Dr. Rohatgi worked at the London Oncology Clinic on Harley Street in London, one of the United Kingdom's most respected cancer centers, where he further refined his clinical acumen in a high-volume international setting.

Fortis Memorial Research Institute is a NABH-accredited, multi-specialty tertiary care center with state-of-the-art oncology facilities, including dedicated chemotherapy units, advanced diagnostic imaging, and a strong supportive care infrastructure. The hospital attracts international patients through its combination of world-class infrastructure, experienced medical teams, and comprehensive patient support services including translation assistance and international patient liaison offices. Gurgaon's proximity to Delhi and excellent international connectivity make it an ideal destination for medical tourism. For international patients seeking cancer treatment with a physician trained to the highest UK standards but rooted in Indian clinical practice, Dr. Rohatgi offers an evidence-based, compassionate approach backed by years of clinical leadership.